Clinical Trial Update: Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer [Phase 4]

View source ↗

Summary

This Phase 4 trial update assesses the safety of cabazitaxel (Jevtana) in patients with metastatic castration-resistant prostate cancer. The study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Sanofi | Conditions: Prostate Cancer Metastatic | Phase 4 | Status: COMPLETED